Literature DB >> 2557657

Platelet-activating factor (PAF) stimulates phosphatidylinositol hydrolysis in human peripheral blood mononuclear leukocytes.

D S Ng1, K Wong.   

Abstract

Human peripheral blood mononuclear leukocytes were labeled with myo-[3H]inositol and stimulated by platelet-activating factor (PAF). PAF-induced phosphatidylinositol hydrolysis and inositol-1,4,5-trisphosphate (IP3) formation in a dose-dependent manner. The response was very rapid and transient and parallels the time course of PAF-induced calcium mobilization in the same cells. However, the doses of PAF for inducing IP3 formation were much higher than those for calcium mobilization. PAF-induced IP3 formation was inhibited by PAF receptor antagonist, L-659, 989, but was not altered by either pertussis toxin or cholera toxin. These data suggest that PAF receptor in human peripheral blood mononuclear leukocytes may be coupled through a pertussis toxin-insensitive guanine nucleotide binding protein to a phosphoinositide-specific phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557657

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  2 in total

Review 1.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Hang Yin; Anhua Shi; Junzi Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-08       Impact factor: 3.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.